has just approved the drug Kisqali (ribociclib) in combination with an aromatase inhibitor (AI) as treatment for people with ...

Aromatase inhibitors (AIs) are a class of drugs that block the aromatase enzyme, which is responsible for converting androgens (male hormones) into estrogens (female hormones). These medications ...

Aromatase inhibitors (AIs) are becoming the hormonal treatment of choice for postmenopausal women with early breast cancer. Large, well-controlled clinical studies have established the efficacy ...

"What's important is that these drugs significantly reduce late recurrences," says Isaacs. But she notes that researchers still don't know which strategy works best: taking an aromatase inhibitor ...

Aromatase inhibition could be an alternative to testosterone administration to mitigate declining androgen production in hypogonadal older men. Unlike testosterone replacement, aromatase ...

Medications called estrogen blockers are among ... to estradiol is associated with a number of health issues, including: Aromatase excess syndrome is a rare genetic condition that results in ...

[13] Since this 2004 study, aromatase inhibitor use and any effect on cognition remain under consideration. A 2009 ASCO Breast Cancer Symposium review of five studies evaluated the majority of ...

Arimidex has also been approved as adjuvant therapy -- drugs given after surgery or radiation-- for women with certain types of early breast cancer. Aromatase inhibitors work differently than ...